Stoke Therapeutics Inc (NASDAQ:STOK)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - STOK

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - STOK

  • Market Cap$1.200bn
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS86150R1077

Company Profile

Stoke Therapeutics Inc is engaged in developing antisense oligonucleotide medicines. The medicine increases gene expression to treat genetic epilepsies and other severe monogenic diseases, including genetic conditions affecting the central nervous system, eye, liver, and kidney.

Latest STOK news

Currently there for this company. Visit our news hub for other news .